18F 2Fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) response to predict event-free survival (EFS) in intermediate risk (IR) or high risk (HR) rhabdomyosarcoma (RMS): A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (COG)

Authors :: Marguerite T. Parisi
Lisa A. Teot
Douglas J. Harrison
James R. Anderson
Andrea Hayes-Jordan
Suman Malempati
Torunn I. Yock
Barry L. Shulkin
William H. Meyer
David A. Rodeberg
Brenda J. Weigel
Douglas S. Hawkins
Xinlei Mi
Yueh-Yun Chi
Geoffrey McCowage
Suzanne L. Wolden
Leo Mascarenhas
Sheri L. Spunt
Source :: Journal of Clinical Oncology. 34:10549-10549
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 10549Background: Change in tumor size by anatomic imaging is not a reliable predictor of outcome in RMS. We reviewed metabolic response by FDG-PET for patients with IR and HR RMS enrolled on two CO...

Full Text Access

Tools